INOZYME PHARMA, INC. General and Administrative Expense
INOZYME PHARMA, INC. reported General and Administrative Expense of $5.41 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2025-05-14
- INOZYME PHARMA, INC. general and administrative expense for the quarter ending 2025-03-31 was $5.41M, a 3.34% increase year-over-year.
- INOZYME PHARMA, INC. general and administrative expense for the quarter ending 2024-12-31 was $4.70M, a 2.63% decline year-over-year.
- INOZYME PHARMA, INC. general and administrative expense for the quarter ending 2024-09-30 was $4.96M, a 4.82% increase year-over-year.
- INOZYME PHARMA, INC. general and administrative expense for the quarter ending 2024-06-30 was $5.91M, a 24.94% increase year-over-year.
- INOZYME PHARMA, INC. general and administrative expense for fiscal 2024 was $20.80M, a 0.00% increase from fiscal 2023.
- INOZYME PHARMA, INC. general and administrative expense for fiscal 2023 was $20.80M, a 0.13% decline from fiscal 2022.
- INOZYME PHARMA, INC. general and administrative expense for fiscal 2022 was $20.83M, a 10.04% increase from fiscal 2021.
- INOZYME PHARMA, INC. general and administrative expense for fiscal 2021 was $18.93M, a 79.43% increase from fiscal 2020.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $5.41M 10-Q · filed 2025-05-14 | $10.11M derived: sum of 2 quarters · filed 2025-05-14 | $15.07M derived: sum of 3 quarters · filed 2025-05-14 | $20.98M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $9.66M derived: sum of 2 quarters · filed 2025-03-10 | $15.57M derived: sum of 3 quarters · filed 2025-03-10 | $20.80M 10-K · filed 2025-03-10 |
| 2024-09-30 | $4.96M 10-Q · filed 2024-11-05 | $10.87M derived: sum of 2 quarters · filed 2024-11-05 | $16.10M 10-Q · filed 2024-11-05 | $20.93M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $5.91M 10-Q · filed 2024-08-06 | $11.14M 10-Q · filed 2024-08-06 | $15.97M derived: sum of 3 quarters · filed 2025-05-14 | $20.70M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $5.23M 10-Q · filed 2025-05-14 | $10.06M derived: sum of 2 quarters · filed 2025-05-14 | $14.79M derived: sum of 3 quarters · filed 2025-05-14 | $19.52M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $9.56M derived: sum of 2 quarters · filed 2025-03-10 | $14.29M derived: sum of 3 quarters · filed 2025-03-10 | $20.80M 10-K · filed 2025-03-10 |
| 2023-09-30 | $4.73M 10-Q · filed 2024-11-05 | $9.46M derived: sum of 2 quarters · filed 2024-11-05 | $15.97M 10-Q · filed 2024-11-05 | $21.67M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $4.73M 10-Q · filed 2024-08-06 | $11.24M 10-Q · filed 2024-08-06 | $16.94M derived: sum of 3 quarters · filed 2024-08-06 | $21.66M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $6.51M 10-Q · filed 2024-05-07 | $12.21M derived: sum of 2 quarters · filed 2024-05-07 | $16.93M derived: sum of 3 quarters · filed 2024-05-07 | $22.31M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $10.42M derived: sum of 2 quarters · filed 2024-03-12 | $15.80M derived: sum of 3 quarters · filed 2024-03-12 | $20.83M 10-K · filed 2024-03-12 |
| 2022-09-30 | $4.72M 10-Q · filed 2023-11-07 | $10.11M derived: sum of 2 quarters · filed 2023-11-07 | $15.13M 10-Q · filed 2023-11-07 | $20.34M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $5.38M 10-Q · filed 2023-08-08 | $10.41M 10-Q · filed 2023-08-08 | $15.62M derived: sum of 3 quarters · filed 2023-08-08 | $20.53M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $5.03M 10-Q · filed 2023-05-09 | $10.23M derived: sum of 2 quarters · filed 2023-05-09 | $15.15M derived: sum of 3 quarters · filed 2023-05-09 | $19.58M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $10.12M derived: sum of 2 quarters · filed 2023-03-22 | $14.56M derived: sum of 3 quarters · filed 2023-03-22 | $18.93M 10-K · filed 2023-03-22 |
| 2021-09-30 | $4.92M 10-Q · filed 2022-11-10 | $9.35M derived: sum of 2 quarters · filed 2022-11-10 | $13.72M 10-Q · filed 2022-11-10 | $17.95M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $4.43M 10-Q · filed 2022-08-15 | $8.80M 10-Q · filed 2022-08-15 | $13.04M derived: sum of 3 quarters · filed 2022-08-15 | $16.18M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $4.37M 10-Q · filed 2022-05-10 | $8.60M derived: sum of 2 quarters · filed 2022-05-10 | $11.75M derived: sum of 3 quarters · filed 2022-05-10 | $13.42M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $7.38M derived: sum of 2 quarters · filed 2022-03-15 | $9.05M derived: sum of 3 quarters · filed 2022-03-15 | $10.55M 10-K · filed 2022-03-15 |
| 2020-09-30 | $3.14M 10-Q · filed 2021-11-09 | $4.81M derived: sum of 2 quarters · filed 2021-11-09 | $6.31M 10-Q · filed 2021-11-09 | $7.80M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.67M 10-Q · filed 2021-08-11 | $3.17M 10-Q · filed 2021-08-11 | $4.66M derived: sum of 3 quarters · filed 2021-08-11 | $5.66M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $1.50M 10-Q · filed 2021-05-12 | $2.99M derived: sum of 2 quarters · filed 2021-05-12 | $3.99M derived: sum of 3 quarters · filed 2021-05-12 | $5.06M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.49M derived: sum of 2 quarters · filed 2021-03-25 | $3.56M derived: sum of 3 quarters · filed 2021-03-25 | $4.59M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-12 | $2.07M derived: sum of 2 quarters · filed 2020-11-12 | $3.10M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $1.06M 10-Q · filed 2020-09-03 | $2.09M 10-Q · filed 2020-09-03 |